Hello! You're looking at a policy document report on Overton
We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer? Request a free trial to our platform.
If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.
Identifiers
Overton ID
oecddiscovery-9f18c73c0eb29180fa45b6258f18bc13
Test No. 441: Hershberger Bioassay in Rats
Test No. 441: Hershberger Bioassay in Rats
The Hershberger Bioassay is an in vivo short–term screening test. It evaluates the ability of a chemical to elicit biological activities consistent with androgen agonists, antagonists or 5 á-reductase inhibitors. The current bioassay is based on the changes in weight of five androgen-dependent tissues in the castrate-peripubertal male rat: the ventral prostate, seminal vesicle (plus fluids and coagulating glands), levator ani-bulbocavernosus muscle, paired Cowper’s glands and the glans penis. In order to establish whether a test substance can have androgenic or antiandrogenic action, two – respectively three - dose groups of the test substance, plus positive and vehicle (negative) controls are normally sufficient. The test substance is administered by gavage or subcutaneous injection daily for 10 consecutive days. To test for antiandrogens, the test substance is administered together with a reference androgen agonist. Each treated and control group should include a minimum of 6 animals. The animals ...
Topics in this document
Antiandrogen
Coefficient of variation
Dose (biochemistry)
Androgen receptor
Dihydrotestosterone
Luteinizing hormone
Receptor antagonist
Androgen
Prostate
Testosterone
Ligand (biochemistry)
5α-Reductase
Estrogen
Flutamide
Toxicity
Medical specialties
Anabolic steroid
Finasteride
Injection (medicine)
Median lethal dose
Citations
Cited by 14
other policy documents
(11 of them are from other policy sources)